InvestorsHub Logo
icon url

BioChica

06/08/14 9:20 AM

#28981 RE: ggwpq #28980

I think everyone here and then some, couldn't agree more. The response to EPADI CP was very disturbing. 'It's complicated' nothing complicated about, EPA ability to neutralize/reduce soft plaque, which would prevent/reduce eruptions (break-offs, is validated. I am in a higher then normal risk, I think Vascepa should be used in for lower risk CV patiants ,risk prevention. A proactive use rather than reactive.

The FDA's actions, are an insult to intelligent Americans!

icon url

RobinF

06/08/14 1:45 PM

#28988 RE: ggwpq #28980

Interesting that you posted that. I was just looking at Tom Hanks last night and how he now has Type II Diabetes because of losing and gaining weight for so many roles. Certainly, he could have and could still benefit from Vascepa in helping to manage his diabetes and cardiovascular health. I wonder if he even knows about Vascepa.